ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma | |
Jin, Hekun; Xie, Xiaoxue; Wang, Hui; Hu, Jun; Liu, Feng; Liu, Zhigang; Zhou, Jumei; Zhang, Yingying; Xi, Xuping; Hu, Bingqiang | |
刊名 | PLOS ONE |
2014 | |
卷号 | 9期号:7页码:e101256 |
关键词 | Radiation therapy,DNA repair,Cancer treatment,Nasopharyngeal carcinoma,Variant genotypes,DNA damage,Heredity,Multivariate analysis |
ISSN号 | 1932-6203 |
DOI | 10.1371/journal.pone.0101256 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000339992400012 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3339829 |
专题 | 中南大学 |
作者单位 | 1.[Jin, Hekun 2.Liao, Yuping 3.Zhang, Yingying] Cent S Univ, Xiangya Hosp, Dept Radiat Oncol, Changsha, Hunan, Peoples R China. |
推荐引用方式 GB/T 7714 | Jin, Hekun,Xie, Xiaoxue,Wang, Hui,et al. ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma[J]. PLOS ONE,2014,9(7):e101256. |
APA | Jin, Hekun.,Xie, Xiaoxue.,Wang, Hui.,Hu, Jun.,Liu, Feng.,...&Tang, Jingtian*.(2014).ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma.PLOS ONE,9(7),e101256. |
MLA | Jin, Hekun,et al."ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma".PLOS ONE 9.7(2014):e101256. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论